ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000237883.1	Gefitinib	Bladder urothelial carcinoma	0.000248303	Sensitive
ENSG00000237883.1	Gefitinib	Breast invasive carcinoma	0.018647997	Sensitive